Liposomal Vitamin D3 as A Dual Modulator of Bone Density and Estrogen Homeostasis in Postmenopausal Osteoporosis Model
Keywords:
Postmenopausal Osteoporosis, Liposome Vitamin D3, Bone Loss, Mineral Homeostasis, Maternal Health Application, Postmenopausal osteoporosis model, Liposomal vitamin D3, Estrogen homeostasis, Bone remodeling, Ovariectomized miceAbstract
Postmenopausal osteoporosis, driven by estrogen decline, leads to significant bone loss and increased fracture risk. This study evaluated if a liposomal vitamin D3 (VD3) formulation offers superior therapeutic benefits over conventional VD3 in an ovariectomized (OVX) mouse model of postmenopause, based on the rationale that enhanced liposomal bioavailability may amplify VD3’s mechanistic role in regulating steroidogenesis and estrogen homeostasis. Thirty-six female BALB/c mice were ovariectomized and allocated into 6 groups (n = 6/group): Control groups or treatment groups receiving conventional VD3 (2,000 IU) or liposomal VD3 (1,000, 2,000, or 4,000 IU) daily for 2 months. Serum estrogen, calcium, phosphorus, and femoral bone histomorphometry (specifically trabecular area and osteoblast, osteoclast, and osteocyte counts) were analyzed. Liposomal VD3 at 2,000 IU and 4,000 IU doses significantly restored serum estrogen levels, an effect not seen with the conventional form. The 2000 IU liposomal dose was most effective, restoring the trabecular area to near-normal levels and was unique among the interventions in significantly increasing the osteoblast population. All VD3 treatments reduced osteoclast numbers; however, the liposomal formulation showed no superiority in elevating serum calcium compared to the standard form. In conclusion, liposomal VD3 (2000 IU) is significantly more effective than its conventional counterpart in reversing bone loss and restoring estrogen by beneficially modulating bone cell populations. Its primary advantage lies in hormonal regulation and bone remodeling rather than mineral homeostasis, highlighting it as a promising strategy for managing postmenopausal osteoporosis.
HIGHLIGHTS
- Liposomal Vitamin D3 (2,000 IU) significantly restored serum estrogen levels in ovariectomized mice—an effect that was not achieved by the conventional formulation.
- The 2,000 IU liposomal dose was the most effective intervention for reversing bone loss, successfully restoring the femoral trabecular area to near-normal levels and being the only treatment to significantly increase the osteoblast population.
- The primary advantage of the liposomal formulation lies in its ability to regulate hormones and bone remodeling rather than acute calcium homeostasis, as it showed no superiority over the standard form in raising serum calcium levels.
- The highest liposomal dose tested (4,000 IU) indicated a potential therapeutic limit; despite its efficacy in other areas, it caused a significant decrease in osteocyte counts compared to normal controls, suggesting that dosage optimization is critical for safety.
GRAPHICAL ABSTRACT
Downloads
References
S Kavosian, G Amirbozorgi, T Shomali, H Hashempoor, M Khorshidi, AA Ahmadi, H Haghi-Aminjan, M Asouri, A Alizadeh, R Ataee, SMB Hashemi and H Akhavan Niaki. Association between vitamin D receptor gene Fok1 polymorphism and bone mineral density in a population of postmenopausal women with osteoporosis. Journal of Mazandaran University of Medical Sciences 2014; 24(118), 73-82.
EF Hamzah, MF Smaism and AH Al-Algawy. Investigation of the role of VDR C>A rs7975232 SNP in the incidence of osteoporosis in Iraqi women. International Journal of Drug Delivery Technology 2021; 11(4), 1190-1194.
GA Reinhart. Vitamin D analogs: Novel therapeutic agents for cardiovascular disease?. Current Opinion in Investigational Drugs 2004; 5(9), 947-951.
BE Kream and AC Lichtler. Vitamin D regulation of type I collagen expression in bone. In: D Feldman, JW Pike and JS Adams (Eds.). Academic Press, San Diego, 2011, p. 403-409.
S Körmendi, B Vecsei, S Ambrus, K Orhan and C Dobó-Nagy. Evaluation of the effect of vitamin D3 on mandibular condyles in an ovariectomized mouse model: A micro-CT study. BMC Oral Health 2021; 21(1), 627.
A Kaspiris, ID Iliopoulos, E Chronopoulos, OD Savvidou, E Vasiliadis and S Kotsela. Implication of vitamin D deficiency in altered osseous remodeling and development of bone marrow edema syndrome. In: J Andělová (Ed.). The essential guide to vitamin D. Nova Science Publishers, New York, 2019, p. 109-122.
M Yamaguchi and MN Weitzmann. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro. International Journal of Molecular Medicine 2012; 29(5), 934-938.
V Yanachkova, R Staynova, S Stoev and E Naseva. Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome. European Journal of Hospital Pharmacy 2023; 30(5), 284-287.
SH Hong, JE Lee, SM An, YY Shin, DY Hwang, SY Yang, SK Cho and BS An. Effect of vitamin D3 on biosynthesis of estrogen in porcine granulosa cells via modulation of steroidogenic enzymes.Toxicological Research 2017; 33(1), 49-54.
S Bakhshalizadeh, F Amidi, R Shirazi and MS Nashtaei. Vitamin D3 regulates steroidogenesis in granulosa cells through AMP-activated protein kinase (AMPK) activation in a mouse model of polycystic ovary syndrome. Cell Biochemistry and Function 2018; 36(4), 183-193.
EC Mbegbu, CT Mbah, IR Obidike and LO Aka. Oral supplementation of VD3 regulates estrous cycle due to its estrogenic effects in rats. Pakistan Veterinary Journal 2020; 40(4), 585-590.
J Gattineni, P Alphonse, Q Zhang, N Mathews, CM Bates and M Baum. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4. American Journal of Physiology. Renal Physiology 2014; 306(3), F351-F358.
NA Mohammed, NF El-Malkey, AA Ibrahim and DM Abdullah. VD3 supplementation ameliorates ovariectomy-induced cardiac apoptotic and structural changes in adult albino rats. Canadian Journal of Physiology and Pharmacology 2019; 97(7), 647-654.
T Vulcan, TS Suciu, LM Lenghel, VA Toma, N Decea and R Moldovan. The impact of VD3 administration and of high fat diet on oxidative stress and inflammation in experimentally induced polycystic ovary syndrome. Medical and Pharmacy Reports 2024; 97(4), 516-627.
CY Lai, JY Yang, S Rayalam, MA Della-Fera, S Ambati and RD Lewis. Preventing bone loss and weight gain with combinations of vitamin D and phytochemicals. Journal of Medicinal Food 2011; 14(11), 1352-1362.
M Li, DR Healy, HA Simmons, HZ Ke and DD Thompson. Alfacalcidol restores cancellous bone in ovariectomized rats. Journal of Musculoskeletal & Neuronal Interactions 2003; 3(1), 39-46.
H Hongo, M Sasaki, T Hasegawa and N Amizuka. Clinical application of active VD3 and its analogues for bone diseases. Clinical Calcium 2011; 21(11), 63-70.
M Noa, S Mendoza, R Mas, N Mendoza and E Goicochea. Long-term effects of D-003, a mixture of high molecular weight acids from sugarcane wax, on bones of ovariectomized rats: A one year study. Pharmazie 2008; 63(6), 486-488.
C Galeşanu, C Ciubotariu, G Melnic and MR Galeşanu. Postmenopausal osteoporosis. Digital Rx radiogrammetry in the diagnosis and follow-up of treatment with alfacalcidol. Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi 2006; 110(4), 833-841.
M Demirbilek, N Laçin Türkoglu, S Aktürk and C Akça. VitD3-loaded solid lipid nanoparticles: stability, cytotoxicity and cytokine levels. Journal of Microencapsulation 2017; 34(5), 454-462.
N Ignjatović, V Uskoković, Z Ajduković and D Uskoković. Multifunctional hydroxyapatite and poly(D,L-lactide-co-glycolide) nanoparticles for the local delivery of cholecalciferol. Materials Science and Engineering: C 2013; 33(2), 943-950.
RC Pereira, IB Salusky, RE Bowen, EG Freymiller and K Wesseling-Perry. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone. Bone 2019; 127, 626-634.
T Rolvien, M Krause, A Jeschke, T Yorgan, K Püschel and T Schinke. Vitamin D regulates osteocyte survival and perilacunar remodeling in human and murine bone. Bone 2017; 103, 78-87.
Y Nakamichi, N Udagawa, T Suda and N Takahashi. The Journal of Steroid Biochemistry and Molecular Biology 2018; 177, 70-76.
Y Nakamichi, N Takahashi, T Suda and N Udagawa. Osteoclastogenesis and vitamin D. In: D Feldman and JW Pike (Eds.). Feldman and Pike’s vitamin D. Academic Press, Massachusetts, 2024, p. 395-408.
PR Ebeling. Vitamin D and osteoporosis. In: M Hewison, R Bouillon, E Giovannucci, D Goltzman, M Meyer and J Welsh (Eds.). Feldman and Pike’s vitamin D: Volume two: Disease and therapeutics. Mosby, Missouri, 2024, p. 411-433.
JF Aloia, R Dhaliwal, A Shieh, M Mikhail, M Fazzari and L Ragolia. Vitamin D supplementation increases calcium absorption without a threshold effect. American Journal of Clinical Nutrition 2014; 99(3), 624-631.
K Uenishi, M Tokiwa, S Kato and M Shiraki. Stimulation of intestinal calcium absorption by orally administrated VD3 compounds: A prospective open-label randomized trial in osteoporosis. Osteoporosis International 2018; 29(3), 723-732.
RHM Salama, SS Ali, THM Salama, MA Almged, TA Alsanory and AA Alsanory. Dietary effects of nanopowder eggshells on mineral contents, bone turnover biomarkers, and regulators of bone resorption in healthy rats and ovariectomy-induced osteoporosis rat model. Applied Biochemistry and Biotechnology 2023; 195(8), 5034-5052.
M Ezcurra-Hualde, S Zalba, Á Bella, L Arrizabalaga, A Risson, R García-Fuentes, C Gomar, N Ardaiz, V Belsue, D Ruiz-Guillamon, A Serrano-Alcaide, A Sargado, F Aranda, MJ Garrido and P Berraondo. Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth. Frontiers in Immunology 2025; 16, 1529007.
Y Tayem, R Alotaibi, R Hozayen and A Hassan. Therapeutic regimens for vitamin D deficiency in postmenopausal women: A systematic review. Przeglad Menopauzalny 2019; 18(1), 57-62.
IY Torshin, OA Gromova and NK Tetruashvili. Concerning effective and safe dosages of vitamin D3: Mega-analysis of clinically effective studies as a basis for actual evidence. Meditsinskiy Sovet Medical Council 2021; 13, 112-120.
P Dałek, D Drabik, H Wołczańska, A Foryś, M Jagas, N Jędruchniewicz, M Przybyło, W Witkiewiczand and M Langner. Bioavailability by design - vitamin D3 liposomal delivery vehicles. Nanomedicine 2022; 43, 102552.
Y Nakamichi and N Takahashi. Current topics on vitamin D. The role of active forms of vitamin D in regulation of bone remodeling. Clinical Calcium 2015; 25, 395-402.
Y Nakamichi, Z Liu, T Mori, Z He, H Yasuda, N Takahashi and N Udagawa. The vitamin D receptor in osteoblastic cells but not secreted parathyroid hormone is crucial for soft tissue calcification induced by the proresorptive activity of 1,25(OH)2D3. The Journal of Steroid Biochemistry and Molecular Biology 2023; 232, 106351.
T Hasegawa, T Yamamoto, S Sakai, Y Miyamoto, H Hongo, Z Qiu, M Abe, S Takeda, K Oda, PHL de Freitas, M Li, K Endo and N Amizuka. Histological effects of the combined administration of Eldecalcitol and a parathyroid hormone in the metaphyseal trabeculae of ovariectomized rats. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 2019; 67(3), 169-184.
H Drissi, A Pouliot, C Koolloos, JL Stein, JB Lian, GS Stein and AJ van Wijnen. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Experimental Cell Research 2002; 274(2), 323-333.
D Yang, PH Anderson, AR Wijenayaka, KR Barratt, R Triliana, CJM Stapledon, H Zhou, DM Findlay, HA Morris and GJ Atkins. Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D3 on osteoblast differentiation. The Journal of Steroid Biochemistry and Molecular Biology 2018; 177, 83-90.
PA Baldock, GP Thomas, JM Hodge, SU Baker, U Dressel, PD O’Loughlin, GC Nicholson, KH Briffa, JA Eisman and EM Gardiner. Vitamin D action and regulation of bone remodeling: Suppression of osteoclastogenesis by the mature osteoblast. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research 2006; 21(10), 1618-1626.
A Fratter and M Pellizzato. Novel micellar system for vitamin D3 oral delivery: Assessment of enteric absorption through a digestion-like in vitro model. Journal of Drug Delivery Science and Technology 2020; 59, 101840.
RK Marwaha, T Dev, A Mittal, K Mani, A Narang, P Arora, A Singh, A Chadha, N Dang, M Goel, VK Sharma and G Sethuraman. A randomised controlled trial comparing the efficacy of micellised and fat-soluble vitamin D3 supplementation in healthy adults. The British Journal of Nutrition 2019; 121(8), 859-865.
J Solnier, C Chang, Y Zhang, YC Kuo, M Du, YS Roh, J See, J Brix, RJ Gahler, T Green and S Wood. A comparison and safety evaluation of micellar versus standard vitamin D3 oral supplementation in a randomized, double-blind human pilot study. Nutrients 2024; 16, 1573.
G Anjani, R Achmad Maulana, SR Putri, F Fulyani, A Syauqy, DN Afifah, F Ayustaningwarno, RA Kusuma and Z Masruroh. Ameliorative effect of liprotide-encapsulated vitamin D3 on blood glucose, calcium homeostasis, and vitamin D level in a vitamin D and calcium deficient rat model. Frontiers in Nutrition 2025; 12, 1514179.
H Annappa, A Tamatam, I Nallamuthu and K Ranganathan. Formulation of pH-responsive nanoparticles using zein/sodium alginate polymers for enhanced bioavailability of the vitamin D3. International Journal of Biological Macromolecules 2025; 313, 144140.
SJ Park, CV Garcia, GH Shin and JT Kim. Development of nanostructured lipid carriers for the encapsulation and controlled release of vitamin D3. Food Chemistry 2017; 225, 213-219.
J Chen, L Dehabadi, YC Ma and LD Wilson. Development of novel lipid-based formulations for water-soluble vitamin C versus fat-soluble vitamin D3. Bioengineering 2022; 9(12), 819.
YP Kharode, MC Sharp and PV Bodine. Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery. Methods in Molecular Biology 2008; 455, 111-124.
CM Esteves, RM Moraes, FC Gomes, MS Marcondes, GM Lima and AL Anbinder. Ovariectomy-associated changes in interradicular septum and in tibia metaphysis in different observation periods in rats. Pathology, Research and Practice 2015; 211, 125-129.
CH Chang, SJ Yang, TH Young and WC Yao. Effect of co-loaded vitamin D3 on intravenous injectable raloxifene delivery system. Colloids and Surfaces B: Biointerfaces 2025; 246, 114379.
P Sharifan, A Ziaee, S Darroudi, M Rezaie, M Safarian, S Eslami, M Khadem-Rezaiyan, M Tayefi, M Bajgiran, H Ghazizadeh, Z Khorasanchi, M Bagherniya, MA Sardar, G Ferns, H Vatanparast and MG Mobarhan. Effect of low-fat dairy products fortified with 1500IU nano encapsulated vitamin D3 on cardiometabolic indicators in adults with abdominal obesity: A total blinded randomized controlled trial. Current Medical Research and Opinion 2021; 37(4), 579-588.
S Qiu, G Divine and SD Rao. Effect of vitamin D metabolites on bone histomorphometry in healthy black and white women: An attempt to unravel the so-called vitamin D paradox in blacks. Bone Reports 2022; 18, 101650.
A Zittermann, JB Ernst, S Prokop, U Fuchs, J Dreier, J Kuhn, HK Berthold, S Pilz, I Gouni-Berthold and JF Gummert. Vitamin D supplementation and bone turnover in advanced heart failure: The EVITA trial. Osteoporosis International 2018; 29(3), 579-586.
GN Varlıhan, ÖB Ağralı, HS Güngörmek, SD Delipınar, L Kuru and HÖ Özener. Vitamins K2 and D3 enhance guided bone regeneration in rat calvarial bone defects. Journal of Periodontology 2025. https://doi.org/10.1002/jper.11372
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
